Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S18B (MRPS18B) is a nuclear-encoded protein that is a component of the small (28S) subunit of the mitochondrial ribosome, where it serves as a structural constituent essential for mitochondrial protein synthesis. Unlike prokaryotic ribosomes, mammalian mitoribosomes have a higher protein-to-rRNA ratio and lack certain rRNA species, such as 5S rRNA. MRPS18B is a member of the ribosomal protein S18P family and one of three human mitochondrial S18-like proteins, each with significant sequence divergence. The gene is located on chromosome 6 and is essential for translation within mitochondria, thereby impacting mitochondrial function and cellular energy production. Variants in MRPS18B have been associated with rare diseases like Leigh disease and megaesophagus but it has no established role as a direct therapeutic target or biomarker[1][2][3][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S18B (MRPS18B).